Skip to main content
Indoco Remedies Ltd. logo

Indoco Remedies Ltd. — Investor Relations & Filings

Ticker · INDOCO ISIN · INE873D01024 LEI · 3358007XE9RRPHJA6U47 BSE.NS Manufacturing
Open in API
Filings indexed 774 across all filing types
Latest filing 2019-05-15 Regulatory Filings
Country IN India
Listing BSE.NS INDOCO

About Indoco Remedies Ltd.

https://www.indoco.com/

Indoco Remedies Ltd. is a fully integrated pharmaceutical company engaged in the research, development, manufacturing, and marketing of finished dosages and Active Pharmaceutical Ingredients (APIs). The company operates multiple manufacturing facilities equipped to produce various dosage forms, including tablets, capsules, injectables, ophthalmics, and topical preparations. Its therapeutic portfolio spans stomatologicals, anti-infectives, respiratory, cardiovascular, anti-diabetics, and pain management. Indoco maintains a significant global footprint, exporting products to over 55 countries, including highly regulated markets such as the United States and Europe. The organization is recognized for its strong research and development capabilities, focusing on complex generics and niche formulations. Key brands include Sensodent-K, Febrex Plus, and Cyclopam, reflecting its leadership in specific therapeutic segments.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results/Dividend
Regulatory Filings Classification · 100% confidence The document text is extremely short (59 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, no report content, no announcements, or any other information to classify as a specific report type. Given the lack of content, the document does not fit any specific filing category and defaults to the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2019-05-15 English
Press Release
Regulatory Filings Classification · 90% confidence The document text is extremely short (376 characters) and contains only address and listing information for stock exchanges without any substantive content or financial data. There is no indication of a report, announcement, or detailed filing. Given the lack of content and the nature of the text, it appears to be a regulatory or listing-related communication without specific report details. Therefore, it fits best under the fallback category Regulatory Filings (RNS).
2019-05-08 English
Press Release
Regulatory Filings Classification · 90% confidence The document text is extremely short (419 characters) and consists mainly of an address and scrip codes for stock exchanges. There is no substantive content, financial data, or report information. It appears to be a brief communication or cover letter rather than a full report or announcement. Given the lack of detailed content and the nature of the text, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous filings that do not fit other specific categories.
2019-04-24 English
Disc. under Reg.30 of SEBI (SAST) Reg.2011
Regulatory Filings
2019-04-16 English
Trading Window
Regulatory Filings
2019-04-04 English
Disc. under Reg.30 of SEBI (SAST) Reg.2011
Regulatory Filings
2019-04-01 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.